XSHE
300171
Market cap1.68bUSD
Dec 05, Last price
15.62CNY
1D
1.49%
1Q
10.08%
Jan 2017
4.90%
IPO
42.78%
Name
Tofflon Science and Technology Group Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It offers injectables, such as auto solution preparation systems, aseptic filling lines for ampoule, vials, syringes and powders, freeze dryer and auto loading systems, barrier systems, and plastic packaging machines. The company also provides active pharmaceutical ingredients; and visual inspection, leak detection, and combination systems, as well as focuses on providing bio-process equipment and integrated systems, including medium preparation, cell/microbial cultivation, harvesting, DF/UF, purification, buffer preparation, and finished filling systems. In addition, it offers lyophilization injectable lab services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. The company was founded in 1993 and is headquartered in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||